WASHINGTON, November 1, 2023 – The ERISA Industry Committee (ERIC) today submitted a comment letter to the Ohio House of Representatives Insurance Committee urging the panel to amend House Bill 291 to include access to all biosimilar products, a necessary step to ensure that the bill will promote competition, and drive lower drug costs for Ohioans.
Topic Archives:
The ERISA Industry Committee Criticizes Proposed New York State Regulations Covering Pharmacy Benefit Managers
WASHINGTON, October 18, 2023 – The ERISA Industry Committee (ERIC) submitted public comments this week expressing deep concerns with regulations proposed by the New York State Department of Financial Services in “Proposed Consolidated Rulemaking for Insurance Regulations 219, 224, and 226-229,” which would implement a state statute enacted in 2021 covering pharmacy benefit managers (PBMs) and their network practices.
ERIC, Coalition Allies File Amicus Brief Supporting AT&T Appeal Effort in Recordkeeping Claims Case
WASHINGTON, September 11, 2023 – The ERISA Industry Committee (ERIC) today filed a coalition amicus brief together with other groups representing sponsors and service providers of employee benefit plans in Bugielski et. al. v. AT&T, arguing that the decision by the United States Court of Appeals for the Ninth Circuit will have far-reaching negative consequences for plan participants, sponsors, and fiduciaries.
ERIC Legal Update – Federal District Court Finds Additional Regulations to Conflict with Terms of No Surprises Act in TMA III Case
Sorry, but you do not have permission to view this content.
ERISA Industry Committee Hails 10th Circuit’s Reversal of PCMA v. Mulready
The ERISA Industry Committee (ERIC) today lauded the 10th U.S. Circuit Court of Appeals’ reversal yesterday of a previous District Court decision in PCMA v. Mulready regarding provisions of an Oklahoma law controlling pharmacy benefit manager (PBM) practices.
ERIC Legal Update: Tenth Circuit Holds Oklahoma PBM Law Preempted by ERISA
Sorry, but you do not have permission to view this content.
The ERISA Industry Committee Urges Ninth Circuit to Affirm ERISA Preemption of California State Law Claims
WASHINGTON, June 29, 2023 – The ERISA Industry Committee (ERIC) joined with two like-minded groups on Wednesday to file an amicus brief with the Ninth Circuit Court of Appeals in Bristol SL Holdings, Inc. v. Cigna Health & Life Ins. Co.
The ERISA Industry Committee Urges Rejection of New Jersey Health Care Bill
WASHINGTON, June 22, 2023 – The ERISA Industry Committee (ERIC) today submitted written testimony in opposition to New Jersey Assembly Bill 536/2841, asserting the legislation under consideration by the New Jersey Assembly Appropriations Committee oversteps state authority and seeks to control self-insured employer health care plans governed by the federal Employee Retirement Income Security Act of 1974 (ERISA). ERIC believes that the legislation would raise health insurance and prescription drug costs for New Jersey employers and employees.
ERIC New Jersey WARN Act Litigation – Decision to Not Pursue Third Circuit Appeal
Sorry, but you do not have permission to view this content.
The ERISA Industry Committee Leads Coalition Amicus Brief Supporting Legal Challenge to Oklahoma Law on ERISA Preemption Grounds
WASHINGTON, April 11, 2023 – The ERISA Industry Committee (ERIC) joined with like-minded coalition groups yesterday to file an amicus brief supporting the legal fight to defeat expansive provisions of Oklahoma law governing the design of employer health plans’ provider networks. These provisions overstep state authority in this area and should be preempted by federal law.